[Form 4] AvePoint, Inc. Insider Trading Activity

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) – Form 4 insider filing

The filing reports that director Jeff Teper received an equity award on 20 June 2025. The grant consists of 9,744 restricted stock units (RSUs), each convertible into one share of common stock upon vesting. The RSUs carry a reference price of $17.96 and will vest 100 % on 1 June 2026, conditional on Teper’s continued service.

Following this award, Teper’s total beneficial ownership increased to 319,305 AVPT shares, held directly. No derivative securities, dispositions, or open-market purchases were disclosed.

The transaction reflects routine board compensation and represents roughly 0.1 % of AvePoint’s 206 million basic shares outstanding (based on latest 10-Q), implying an immaterial dilution impact.

Positive

• Director equity alignment: Grant of 9,744 RSUs ties Jeff Teper’s compensation to long-term share performance, reinforcing governance alignment.

Negative

• Minor dilution: Issuance of new shares, though immaterial (<0.01 % of float), incrementally increases share count.

Insights

Financial Analyst

TL;DR: Routine RSU grant to director; negligible dilution, modest signal of board alignment; low overall market impact.

The Form 4 shows a standard annual equity grant—9,744 RSUs—to director Jeff Teper at a reference price of $17.96. Post-grant ownership rises to 319,305 shares, indicating continued personal exposure to AvePoint’s share performance. The award vests in a single tranche on 1 June 2026, aligning the director’s incentives with long-term shareholder value.

Because the share count is de minimis relative to AvePoint’s float, dilution is immaterial (<0.01 %). No sales or option exercises were reported, so there is no negative liquidity signal. For investors, the filing is largely administrative and should not alter fundamental or valuation views.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Teper Jeff

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/20/2025		A		9,744(2)	A	$17.96	319,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. 100% of the RSUs will vest on June 1, 2026, following the Reporting Person's continued service with the Issuer as of that vesting date.

	/s/ Brian Michael Brown, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AvePoint (AVPT) shares did Jeff Teper receive?

9,744 restricted stock units, each converting into one common share upon vesting.

What is the vesting schedule for the new AVPT RSUs?

The RSUs vest 100 % on 1 June 2026, contingent on Teper’s continued service.

What is Jeff Teper’s total beneficial ownership in AVPT after this transaction?

319,305 shares held directly.

Was any AVPT stock sold in this Form 4 filing?

No. The filing only reports an award of RSUs; there were no dispositions.

Does the RSU grant significantly dilute existing AvePoint shareholders?

Dilution is immaterial; 9,744 shares represent about 0.01 % of AvePoint’s basic share count.